Regeneron Pharmaceuticals (REGN) Q3 2025 Earnings

1AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
8.22
9.78
11.33
12.89

Details

Expected EPS
8.430906
Actual EPS
12.89
Surprise EPS
4.46
Surprise Percent
+52.89%

Description

Regeneron Pharmaceuticals (REGN) has reported earnings of 12.89 per share for Q3 2025.

0 Comments

Share your thoughts